106 related articles for article (PubMed ID: 7488016)
1. Expression of the chemokine receptor BLR2/EBI1 is specifically transactivated by Epstein-Barr virus nuclear antigen 2.
Burgstahler R; Kempkes B; Steube K; Lipp M
Biochem Biophys Res Commun; 1995 Oct; 215(2):737-43. PubMed ID: 7488016
[TBL] [Abstract][Full Text] [Related]
2. Cloning of human and mouse EBI1, a lymphoid-specific G-protein-coupled receptor encoded on human chromosome 17q12-q21.2.
Schweickart VL; Raport CJ; Godiska R; Byers MG; Eddy RL; Shows TB; Gray PW
Genomics; 1994 Oct; 23(3):643-50. PubMed ID: 7851893
[TBL] [Abstract][Full Text] [Related]
3. Reduced signal transduction through glucocorticoid receptor in Burkitt's lymphoma cell lines.
Sinclair AJ; Jacquemin MG; Brooks L; Shanahan F; Brimmell M; Rowe M; Farrell PJ
Virology; 1994 Mar; 199(2):339-53. PubMed ID: 8122366
[TBL] [Abstract][Full Text] [Related]
4. The Epstein-Barr virus nuclear antigen 2 (EBNA2), a protein required for B lymphocyte immortalization, induces the synthesis of type I interferon in Burkitt's lymphoma cell lines.
Kanda K; Kempkes B; Bornkamm GW; von Gabain A; Decker T
Biol Chem; 1999 Feb; 380(2):213-21. PubMed ID: 10195428
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus nuclear antigen 2 is a transcriptional suppressor of the immunoglobulin mu gene: implications for the expression of the translocated c-myc gene in Burkitt's lymphoma cells.
Jochner N; Eick D; Zimber-Strobl U; Pawlita M; Bornkamm GW; Kempkes B
EMBO J; 1996 Jan; 15(2):375-82. PubMed ID: 8617212
[TBL] [Abstract][Full Text] [Related]
6. Identification of the Epstein-Barr virus nuclear antigen 2 transactivation domain.
Horvath GC; Schubach WH
Biochem Biophys Res Commun; 1993 Feb; 191(1):196-200. PubMed ID: 8383488
[TBL] [Abstract][Full Text] [Related]
7. Efficient EBV superinfection of group I Burkitt's lymphoma cells distinguishes requirements for expression of the Cp viral promoter and can activate the EBV productive cycle.
Evans TJ; Jacquemin MG; Farrell PJ
Virology; 1995 Feb; 206(2):866-77. PubMed ID: 7856099
[TBL] [Abstract][Full Text] [Related]
8. Regulation of interleukin-1beta transcription by Epstein-Barr virus involves a number of latent proteins via their interaction with RBP.
Krauer KG; Belzer DK; Liaskou D; Buck M; Cross S; Honjo T; Sculley T
Virology; 1998 Dec; 252(2):418-30. PubMed ID: 9878621
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus nuclear antigen 2-estrogen receptor fusion proteins transactivate viral and cellular genes and interact with RBP-J kappa in a conditional fashion.
Kempkes B; Pawlita M; Zimber-Strobl U; Eissner G; Laux G; Bornkamm GW
Virology; 1995 Dec; 214(2):675-9. PubMed ID: 8553575
[TBL] [Abstract][Full Text] [Related]
10. Characterization of natural Epstein-Barr virus infection and replication in smooth muscle cells from a leiomyosarcoma.
Jenson HB; Montalvo EA; McClain KL; Ench Y; Heard P; Christy BA; Dewalt-Hagan PJ; Moyer MP
J Med Virol; 1999 Jan; 57(1):36-46. PubMed ID: 9890420
[TBL] [Abstract][Full Text] [Related]
11. Induction of pleckstrin by the Epstein-Barr virus nuclear antigen 3 family.
Kienzle N; Young D; Silins SL; Sculley TB
Virology; 1996 Oct; 224(1):167-74. PubMed ID: 8862411
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus replicative gene transcription during de novo infection of human thymocytes: simultaneous early expression of BZLF-1 and its repressor RAZ.
Kelleher CA; Paterson RK; Dreyfus DH; Streib JE; Xu JW; Takase K; Jones JF; Gelfand EW
Virology; 1995 Apr; 208(2):685-95. PubMed ID: 7747440
[TBL] [Abstract][Full Text] [Related]
13. In situ RT-PCR detection of Epstein-Barr virus immediate-early transcripts in CD4+ and CD8+ T lymphocytes.
Guan M; Romano G; Henderson EE
Anticancer Res; 1998; 18(5A):3171-80. PubMed ID: 9858880
[TBL] [Abstract][Full Text] [Related]
14. Modulation of expression of insulin and IGF-I receptor by Epstein-Barr virus and its gene products LMP and EBNA-2 in lymphocyte cell lines.
Kriauciunas KM; Goldstein BJ; Lipes MA; Kahn CR
J Cell Physiol; 1993 Mar; 154(3):486-95. PubMed ID: 8382208
[TBL] [Abstract][Full Text] [Related]
15. The normal cell cycle activation program is exploited during the infection of quiescent B lymphocytes by Epstein-Barr virus.
Hollyoake M; Stühler A; Farrell P; Gordon J; Sinclair A
Cancer Res; 1995 Nov; 55(21):4784-7. PubMed ID: 7585505
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the methods for the detection of Epstein-Barr virus nucleic acids and related gene products in Hodgkin's disease.
Brousset P; Meggetto F; Chittal S; Bibeau F; Arnaud J; Rubin B; Delsol G
Lab Invest; 1993 Oct; 69(4):483-90. PubMed ID: 8231115
[TBL] [Abstract][Full Text] [Related]
17. Human p32: a coactivator for Epstein-Barr virus nuclear antigen-1-mediated transcriptional activation and possible role in viral latent cycle DNA replication.
Van Scoy S; Watakabe I; Krainer AR; Hearing J
Virology; 2000 Sep; 275(1):145-57. PubMed ID: 11017796
[TBL] [Abstract][Full Text] [Related]
18. Molecular cloning of a novel human CC chemokine EBI1-ligand chemokine that is a specific functional ligand for EBI1, CCR7.
Yoshida R; Imai T; Hieshima K; Kusuda J; Baba M; Kitaura M; Nishimura M; Kakizaki M; Nomiyama H; Yoshie O
J Biol Chem; 1997 May; 272(21):13803-9. PubMed ID: 9153236
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors.
Birkenbach M; Josefsen K; Yalamanchili R; Lenoir G; Kieff E
J Virol; 1993 Apr; 67(4):2209-20. PubMed ID: 8383238
[TBL] [Abstract][Full Text] [Related]
20. A region of the Epstein-Barr virus nuclear antigen leader protein and adenovirus E1A are identical.
Huen DS; Grand RJ; Young LS
Oncogene; 1988 Dec; 3(6):729-30. PubMed ID: 2577878
[No Abstract] [Full Text] [Related]
[Next] [New Search]
